Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.
about
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesGenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-AnalysisThe effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic reviewThe effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape ProvinceScaling up multidrug-resistant tuberculosis care in ChinaAcquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center.A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' Rifampicin mutations.Improvement in clinical outcome and infection control using molecular diagnostic techniques for early detection of MDR tuberculous spondylitis: a multicenter retrospective study.Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.
P2860
Q26767271-8E49B940-7252-474A-A5F9-88D310B72A47Q28550477-73D95C13-6A61-4D25-8AE0-C5B7E8914043Q28551772-AABDE8F3-4395-4486-A9E6-F7C3670F5F16Q29247880-894FFFB4-C4A6-4ECB-8E1D-F61FF54141D5Q35582880-45305BAC-0223-4B4A-9EEE-10F1D2E37C64Q35673445-A88FC0A9-0634-463D-9904-A7EAAB8D0373Q35971268-349BCF2E-77BE-4133-B0C1-8DB37886E81DQ36035420-B54615B3-28DA-4699-BE15-F2281EBBF17AQ36564933-3E2424BF-0B19-4B36-8427-3CE5F16CF88AQ37231921-9BA2D652-E3F1-431D-8076-EEB65B310303Q38718388-E567D434-CDAA-4CDE-8BEA-333EB2554935Q42687193-CA3E6295-4E57-4072-8306-F2B323C4E9B9Q46669106-58857D3C-F057-4770-9D6D-26EC9A409B1EQ47128432-4987DA9D-D197-43AB-B3E5-BF5367BB0B86Q50044320-54F4BBCF-625F-4A96-B7AA-D92E7556BEA6Q55419989-A0C6712C-72E9-4B43-9C33-AB1722D64562
P2860
Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@ast
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@en
type
label
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@ast
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@en
prefLabel
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@ast
Significant clinical impact of ...... tidrug-resistant tuberculosis.
@en
P2093
P2860
P356
P1476
Significant clinical impact of ...... ltidrug-resistant tuberculosis
@en
P2093
Henry M Blumberg
Maia Kipiani
Matthew Magee
Nestani Tukvadze
Russell R Kempker
P2860
P304
P356
10.1093/CID/CIU631
P407
P577
2014-08-04T00:00:00Z